How do I use my tumor's DNA to find clinical trials

Using Your Tumor's Genetic Information to Find Clinical Trials

Excellent question! Your tumor's DNA (genomic profile) is actually a powerful tool for matching you with clinical trials that might be right for you. Here's how it works:

Why Tumor DNA Matters for Trial Matching

When you have genomic sequencing done, you get a detailed "molecular profile" of your cancer—which genes are mutated, which pathways are active, etc. Clinical trials are increasingly designed to target specific genetic mutations, so knowing your tumor's DNA helps match you to trials testing drugs that work against YOUR specific cancer's weaknesses.

How to Find Trials Using Your Genetic Profile

Step 1: Get Your Genomic Results

• Ask your oncologist for a copy of your genomic sequencing report
• Write down the specific mutations, gene alterations, or biomarkers identified
• Keep this information handy—you'll need it for trial searches

Step 2: Search Trial Databases

National Cancer Institute (NCI) Clinical Trials Database

• Go to cancer.gov/about-cancer/treatment/clinical-trials/search
• Filter by your cancer type AND genetic mutations/biomarkers
• You can search by specific gene names (e.g., "BRCA1," "EGFR," "PD-L1")
• Shows trials at institutions near you

Cancer Commons

• Visit cancercommons.org
• Upload your genomic report and medical history
• Their AI-powered system matches you to relevant trials based on your specific mutations
• Provides personalized trial recommendations

ClinicalTrials.gov

• Go to clinicaltrials.gov
• Search by cancer type + specific mutation (e.g., "lung cancer EGFR mutation")
• Filter by location, trial phase, and recruitment status
• More comprehensive but requires more manual searching

Your Cancer Center's Trial Database

• Ask your oncology team about trials at YOUR institution
• Many major cancer centers have their own trial matching services
• Your doctor may know about trials before they're widely publicized

Step 3: Work With Your Oncology Team

This is crucial—don't pursue trials alone:

• Share your genomic results with your oncologist
• Ask: "Are there clinical trials that match my tumor's genetic profile?"
• Your doctor can assess trial eligibility based on your complete medical picture
• They can help determine if a trial is appropriate for your stage and overall health

What Information From Your Genomic Report Helps Most

When searching, look for these key findings on your report:

• Specific mutations (e.g., EGFR L858R, BRAF V600E, KRAS G12C)
• Gene amplifications (e.g., HER2 amplification, MYC amplification)
• Tumor mutational burden (TMB) - high TMB may qualify you for immunotherapy trials
• Microsatellite instability (MSI) - important for certain trial eligibility
• PD-L1 expression - relevant for immunotherapy trials
• Fusion genes (e.g., ALK fusion, ROS1 fusion)

Real-World Example

If your genomic report shows you have a KRAS G12C mutation in lung cancer:

• Search for trials specifically testing "KRAS G12C inhibitors"
• The FDA has approved sotorasib and adagrasib for this mutation
• Multiple clinical trials may be testing these drugs in combination with other therapies
• Your mutation makes you eligible for these targeted trials

Questions to Ask Your Oncology Team

1. "Based on my genomic results, what clinical trials would you recommend I consider?"
2. "Are there trials at our institution that match my tumor's genetic profile?"
3. "How do I know if I'm eligible for a specific trial?"
4. "What are the potential benefits and risks of participating in a trial?"
5. "If I'm not eligible for trials now, could I be in the future if my cancer progresses?"

Important Considerations

• Trial eligibility is complex - having the right mutation doesn't automatically mean you qualify (stage, performance status, organ function, and other factors matter)
• Timing matters - some trials have specific enrollment windows
• Geographic location - you may need to travel for certain trials
• Your doctor's judgment - they know your complete medical picture and can advise on realistic options

According to the National Cancer Institute, clinical trials are increasingly personalized based on tumor genetics, and matching patients to trials based on their genomic profile is becoming standard practice in oncology.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.